Stocks · Health care · Pharmaceutical Preparations

ALNYLAM PHARMACEUTICALS, INC.

ALNY Clue Score70
United States Fiscal year ends December CIK 0001178670 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Amy W Schulman
13 May 2026
Director
Exercised, kept
11,250
$70.20
$789.75K
Yvonne Greenstreet
26 Nov 2025
Chief Executive Officer
Exercised, kept
659
$151.59
$99.90K
Showing 250 of 284 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 45
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 95
Sales straight out of an exercise 41
Sales at will 143
Transactions with no price 0
Shares from compensation/vesting 173,924
History held since 1 Nov 2006